OPENING OF BANKRUPTCY

OXYPOINT

Export PDF

Company — Opening of bankruptcy.

Financial year 2024 · Closed on 31/12/2024

Net result-624 k €-3,2 %over 1 year

Revenue354,8 k €+59,5 %over 1 year

Equity-747,1 k €-506,9 %over 1 year

Workforce4,3 ETP+30,3 %over 1 year

Identity

Source · BCE/KBO

OXYPOINT is a Public limited company incorporated in 2011. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Niel. It employs on average 4,3 ETP workers (FTE).

Legal situation: Opening of bankruptcy
BCE/KBO no. / VAT: BE 0832.604.943
Incorporation: 06/01/2011
Legal form: Public limited company
Registered office: Galileilaan 15
2845 Niel · FlandreSee on map
Contributed capital: 1 325 472,92 €
Latest accounts: 31/12/2024
Average workforce: 4,3 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 72109Research and experimental development on natural sciences and engineering 72190Other research and experimental development on natural sciences and engineering 77225Rental of video tapes and disks 77295Rental and leasing of other personal and household goods

Joint committees (1)

Contacts

2 public details availableLog in to view

Signals

Healthy social debts

Financials

Source · NBB, 14 filings

Trend over 13 financial years

	2024		2023		2022		2021		2020
Income statement
Revenue	354,8 k €	+59.5%	222,5 k €	+53.8%	144,7 k €	-52.1%	302,2 k €		–
EBITDA	-377,2 k €	-1.1%	-373,3 k €	+41.1%	-633,3 k €	-81.9%	-348,3 k €	-56.3%	-222,8 k €
Operating result	-566 k €	+0.3%	-567,8 k €	+31.0%	-823,3 k €	-60.1%	-514,2 k €	-56.8%	-328 k €
Net result	-624 k €	-3.2%	-604,8 k €	+28.6%	-846,7 k €	-64.1%	-515,9 k €	-56.8%	-329,1 k €
Balance sheet
Equity	-747,1 k €	-507%	-123,1 k €	-126%	481,7 k €	-63.7%	1,3 M €	-28.0%	1,8 M €
Total assets	1,4 M €	-13.2%	1,6 M €	-11.2%	1,8 M €	+0.6%	1,8 M €	-25.2%	2,4 M €
Cash	75,9 k €	-40.8%	128,1 k €	-64.6%	361,6 k €	+9.4%	330,5 k €	-72.1%	1,2 M €
Debts	1,7 M €	+35.0%	1,2 M €	+27.1%	966,6 k €	+1133%	78,4 k €	-34.0%	118,7 k €
Other
Workforce	4,3 ETP	+30.3%	3,3 ETP	0.0%	3,3 ETP	+37.5%	2,4 ETP	-25.0%	3,2 ETP

Board of directors

Source · NBB, accounts to 31/12/2024

5 active · 6 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
GEO-PHARM0667.520.049Represented by Thiéry Damien	Director13/12/2024 → 02/06/2025
Startegica0834.987.381Represented by Guy Lefever	Director03/06/2022 → 01/06/2027
P&L Projects0652.876.118Represented by FRANK PIETERS	Director21/01/2022 → 01/06/2027
COFIMARepresented by LUC HANSEN	Director25/05/2021 → 28/06/2024
Innovamus0501.500.193Represented by Philip Hendrickx	Director23/03/2018 → 13/12/2024Manageruntil 23/03/2018ended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Kenneth Wils	Directorlisted until the 2019 accounts
Dirk Borgonjon	Director26/10/2020 → 2020 accounts
Participatiemaatschappij Vlaanderen0455.777.660Represented by Kenneth Wils	Director30/03/2020 → 2020 accounts

Other companies at this address

Galileilaan 15 2845 Niel

Company	CBE no.
4VISO● Active	1027.105.086
ADM● Active	0463.498.167
BMCDENIS● Active	0834.200.394
BRIGHTSPEC● Active	0846.102.393
CAST4ALL● Active	0469.659.053
CIRCLAIR● Active	1017.358.665
CosProf Studio● Active	1011.646.553
EUROPEAN RESPIRATORY CLUSTER ANTWERP● Active	0692.724.114
FiriX Therapeutics● Active	1024.780.848
GRAND MEDICAL (EUROPE)● Active	0766.800.440
Hemplab Institute● Active	0649.743.810
KARDECO● Active	0427.600.348
Leveraging Affordable Solutions for Advanced Therapies● Active	0732.572.407
MOBILAR● Active	0779.489.327
NSX● Active	0840.966.838
ORYX GROUP● Bankrupt	0835.298.771
ORYX IT SERVICES● Bankrupt	0835.842.565
SIMMOCON● Active	0786.692.269
Sodecon● Active	0678.753.243
Solarpool● Active	1044.809.269

Full financial information

Source · NBB

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	15/07/2025	23/07/2024	12/07/2023	23/05/2022	01/07/2021	03/12/2020
General meeting	26/06/2025	28/06/2024	19/06/2023	02/05/2022	01/06/2021	01/06/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 14 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2024	26/06/2025	15/07/2025	Dutch	PDF
Abridged model	31/12/2023	28/06/2024	23/07/2024	Dutch	PDF
Abridged model	31/12/2022	19/06/2023	12/07/2023	Dutch	PDF
Abridged model	31/12/2021	02/05/2022	23/05/2022	Dutch	PDF
Abridged model	31/12/2020	01/06/2021	01/07/2021	Dutch	PDF
Abridged modelCorrection	31/12/2019	01/06/2020	03/12/2020	Dutch	PDF
Abridged model	31/12/2019	01/06/2020	22/06/2020	Dutch	PDF
Abridged model	31/12/2018	25/04/2019	13/05/2019	Dutch	PDF
Micro model	30/09/2017	26/01/2018	28/03/2018	Dutch	PDF
Abridged model	30/09/2016	06/03/2017	29/03/2017	Dutch	PDF
Abridged model	30/09/2015	07/03/2016	21/03/2016	Dutch	PDF
Abridged model	30/09/2014	01/04/2015	01/04/2015	Dutch	PDF
Abridged model	30/09/2013	13/03/2014	27/03/2014	Dutch	PDF
Abridged model	30/09/2012	04/03/2013	27/03/2013	Dutch	PDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

5 active · 6 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
GEO-PHARM0667.520.049Represented by Thiéry Damien	Director13/12/2024 → 02/06/2025
Startegica0834.987.381Represented by Guy Lefever	Director03/06/2022 → 01/06/2027
P&L Projects0652.876.118Represented by FRANK PIETERS	Director21/01/2022 → 01/06/2027
COFIMARepresented by LUC HANSEN	Director25/05/2021 → 28/06/2024
Innovamus0501.500.193Represented by Philip Hendrickx	Director23/03/2018 → 13/12/2024Manageruntil 23/03/2018ended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Kenneth Wils	Directorlisted until the 2019 accounts
Dirk Borgonjon	Director26/10/2020 → 2020 accounts
Participatiemaatschappij Vlaanderen0455.777.660Represented by Kenneth Wils	Director30/03/2020 → 2020 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates10/03/2025
ONTSLAGEN - BENOEMINGEN
PDF
Registered office08/02/2023
MAATSCHAPPELIJKE ZETEL - ADRESSEN ANDERS DAN MAATSCHAPPELIJKE ZETEL
PDF
Mandates11/05/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/02/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/06/2021
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Mandates29/04/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates29/04/2020
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Other24/12/2019
DIVERSEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings13 filings

Mandates

GEO-PHARM

Startegica

P&L Projects

COFIMA

Innovamus

Kenneth Wils

Dirk Borgonjon

Participatiemaatschappij Vlaanderen

Opigo!

Luc Hansen

David Devigne

20112012201320142015201620172018201920202021202220232024202520262027

OXYPOINT

Galileilaan 15, 2845 Niel

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Galileilaan 15, 2845 NielCurrent	accounts 2022 → 2024	Accounts 2024 · 2025-00282627
Zénobe Grammestraat 34, 2018 Antwerp-2018	accounts 2021	Accounts 2021 · 2022-20033505

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
OXYPOINTCurrent	accounts 2012 → 2024	Accounts 2024 · 2025-00282627

Events

2024
Annual accounts 2024-624 k €↓
2023
Annual accounts 2023-604,8 k €↑
2022
Annual accounts 2022-846,7 k €↓
2021
Annual accounts 2021-515,9 k €↓
2020
Annual accounts 2020-329,1 k €↑
2019
Annual accounts 2019-928,5 k €↓
2018
Annual accounts 2018-809,7 k €↓
2017
Annual accounts 2017-60,3 k €↓
2016
Annual accounts 2016-22,4 k €↑
2015
Annual accounts 2015-29,5 k €↓
2014
Annual accounts 2014-25,5 k €↓
2013
Annual accounts 20136,2 k €↓
2012
Annual accounts 201252,6 k €
06/01/2011
IncorporationPublic limited company

OXYPOINT

Overview

Identity

Financials

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events